NFKB1 and cancer: Considering the central role of HIF1α and NFkB in metabolic reprogramming, inflammation, and cancer, and considering also the fact that both transcription factors are regulated by sirtuins, the possibility to develop more specific modulators acting on different steps of these molecular net, hold promising results toward new therapies with higher success rates.